Maggot Therapy Takes Us Back to the Future of Wound Care: New and Improved Maggot Therapy for the 21st Century

Abstract

In the 21st century, eighty years after William Baer presented his groundbreaking work treating bone and soft tissue infections with live maggots, thousands of therapists around the globe have rediscovered the benefits of maggot therapy. The renaissance in maggot therapy is due in large part to recent technological advancements that have solved or minimized many of the treatment's earlier drawbacks: the need for reliable access to this perishable medical device, simplified application, and low-cost production. Modern dressing materials have simplified the procedure and minimized the risk of escaping maggots. The establishment of dozens of laboratories throughout the world, along with access to overnight courier services in many regions, has made medicinal maggots readily available to millions of people in need. Studies show that fears of patient nonacceptance are unfounded. The medical literature is rapidly growing with scientific evidence demonstrating the efficacy and safety of maggot therapy for a variety of problematic wounds. This article examines how these and other technologies are optimizing the study and application of maggot therapy for wound care.

Maggot Debridement Therapy for Diabetic Foot Ulcer: A Case Report

“…According to the protocol recommended by the American diabetes association (ADA), one of the preventive tactics in diabetes care is multidisciplinary team approach where its advantages are shown in several studies (7,8). The members of the team for diabetic foot care usually consists of general practitioner, nurse, educator, and … Although all team members have an influence on reducing the incidence of a foot ulcer and amputation, however, the role of a nurse is essential (9).…”

Maggot debridement therapy: the current perspectives

“…Six wounds in the MDT group had debrided faster (2-3 days) than in the control arm (>1 month). In the same year (2000), another large RCT was conducted by Markevich et al 23,24 They included 140 patients with non-healing diabetic neuropathic foot wounds. Compared with conventional therapy, the MDT wounds were successfully debrided twice as often in the 10-day follow-up period (51.1% of MDT patients versus 27% of controls, p<0.05).…”

Four Cutaneous Leishmaniosis Case Resistant to Meglumine Antimoniate Treatment

“…Canlı larvaların özellikle S. aureus, A ve B grubu streptokok gibi patojen bakterileri öldürdüğü ya da büyümelerini inhibe ettiği in vitro çalışmalarla ortaya konulmuştur (16).…”